Day: November 20, 2023

LODI, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) — Farmers & Merchants Bancorp (OTCQX: FMCB) (the “Company” or “FMCB”), the parent company of Farmers & Merchants Bank of Central California (the “Bank” or “F&M Bank”), announced that, effective immediately, the Company is extending its existing share repurchase program through December 31, 2024 with an additional $25 million in repurchases authorized through that date. The Company’s repurchase program was first established in 2008 and was last extended in November 2022. Since November 2022, the Company has repurchased and retired 17,126 shares, representing approximately 2.23% of total shares outstanding as of November 30, 2022. Since January 2021 the Company had a reduction of 38,551 shares or 4.88% of shares outstanding through October 31, 2023 due to share repurchases....

HOUSTON, Nov. 20, 2023 (GLOBE NEWSWIRE) — Powell Industries, Inc. (NASDAQ: POWL), a leading supplier of custom engineered solutions for the management, control and distribution of electrical energy, today announced that it will release results for the fiscal fourth quarter and full year ended September 30, 2023 on Tuesday, December 5, 2023 after the market closes. In conjunction with the release, Powell Industries has scheduled a conference call, which will be broadcast live within the Investor Relations section of the Company’s website, on Wednesday, December 6, 2023 at 11:00 a.m. eastern time.     What:   Powell Industries Fiscal 2023 Q4 & Full Year Earnings Conference Call     When:   Wednesday, December 6, 2023 – 11:00 a.m. eastern / 10:00 a.m. central     How:   Live via phone by dialing 1-833-953-2431...

EL SEGUNDO, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) — The board of directors of A-Mark Precious Metals, Inc. (NASDAQ: AMRK) (A-Mark), a leading fully integrated precious metals platform, has authorized an increase in the number of shares which may be repurchased under the Company’s existing share repurchase program. Under the revised program, A-Mark is authorized to repurchase up to 1,221,152 shares of its outstanding common stock, in addition to the 778,848 shares repurchased under the program through November 14, 2023, for a total of 2 million shares. As previously reported, the Company repurchased 171,268 shares during the fiscal first quarter of 2024 ended September 30, 2023. In the fiscal second quarter of 2024, the Company has repurchased an additional 303,417 shares through November 17, 2023. The share repurchase program...

“Communication, transparency and reliability are key to establishing lifetime relationships and success.” Woodlands, TX., Nov. 20, 2023 (GLOBE NEWSWIRE) — BlueFire Equipment Corp. (OTC: BLFR) (“BLFR” or the “Company”), a specialist in emerging industry acquisitions, today announces its third quarter fiscal 2023 financial results, highlights, and outlook. Financial Results: As of September 30, 2023, the Company recorded:$251,451 in Cash, a 9,571% increase compared to the quarter ended September 30, 2022. $10,193,317 in Total assets, a 228% increase compared to the quarter ended September 30, 2022. $783,637 in Revenues, a 3,363% increase compared to the quarter ended September 30, 2022. $623,043 in Net Income, a 2,041% increase compared to the quarter ended September 30, 2022. $169,366 in Net Cash Provided by Operating Activities,...

ATHENS, Greece, Nov. 20, 2023 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that its Board of Directors has declared a distribution of warrants (the “Warrants”) to holders of the Company’s common stock (the “Holders”) as of December 6, 2023 (the “Record Date”). Holders may exercise their Warrants for shares of common stock as will be specified under the terms in the warrant agreement. Details of Warrant Distribution The Warrants will be distributed pro-rata to Holders of the Company’s common stock. Holders will receive one Warrant for every five shares of issued and outstanding shares of common stock held as of the Record Date (rounded down to the nearest whole number for any fractional...

Topline Phase 2b data expected in June 2024 More than 120 sites around the world actively recruiting in the Phase 3 portion of the IMPAHCT trial WALTHAM, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) — Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease, today announced the Phase 2b portion of the Inhaled iMatinib Pulmonary Arterial Hypertension Clinical Trial (IMPAHCT) Phase 2b/Phase 3 study evaluating AV-101, a novel dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension (PAH), has completed enrollment at 202 adult patients. Aerovate expects to report topline data from the Phase 2b portion of the trial in June 2024. In addition, the first patient has...

SAN DIEGO, CA and TAICANG, China, Nov. 20, 2023 (GLOBE NEWSWIRE) — Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T cell-driven research, today announced that it will announce topline results from the Stage 2 (maintenance period) of its China pivotal trial evaluating rademikibart’s efficacy and safety in patients with moderate-to-severe atopic dermatitis (AD) on Tuesday, November 21, 2023, prior to market open. Following the announcement, the Company will host a conference call and webcast presentation at 8:30 a.m. ET to discuss the trial results. Conference Call and Webcast PresentationDate and Time: Tuesday,...

HOLLISTON, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced it will be presenting at the Benchmark Company 12th Annual Discovery One-on-One Investor Conference to be held Thursday December 7th, 2023 at the New York Athletic Club in New York City. The conference offers emerging growth and dynamic publicly traded companies access to institutional and individual investors in a unique one-on-one format during which Jim Green, Chairman and Chief Executive Officer, will be participating in one-on-one meetings with investors and analysts throughout the day. Joining him will be Jennifer Cote, the company’s Chief Financial Officer and Treasurer. To schedule a one-on-one meeting with Harvard Bioscience, Inc., you may submit your request online via the link provided upon registration. To register...